These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 29077574

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
    Rivard MJ, Melhus CS, Granero D, Perez-Calatayud J, Ballester F.
    Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Monte Carlo dosimetry of a novel Yttrium-90 disc source for episcleral brachytherapy.
    Chang X, Huang L, Liu J, Cao Y, Chang J.
    J Appl Clin Med Phys; 2023 Dec; 24(12):e14140. PubMed ID: 37708092
    [Abstract] [Full Text] [Related]

  • 27. Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy.
    Hindié E, Zanotti-Fregonara P, Quinto MA, Morgat C, Champion C.
    J Nucl Med; 2016 May; 57(5):759-64. PubMed ID: 26912441
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G, Reniers B, Murrer L, Lutgens L, Gurp EB, Pignol JP, Keller B, Beaulieu L, Verhaegen F.
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Multifunctional targeted therapy system based on (99m) Tc/(177) Lu-labeled gold nanoparticles-Tat(49-57)-Lys(3) -bombesin internalized in nuclei of prostate cancer cells.
    Jiménez-Mancilla N, Ferro-Flores G, Santos-Cuevas C, Ocampo-García B, Luna-Gutiérrez M, Azorín-Vega E, Isaac-Olivé K, Camacho-López M, Torres-García E.
    J Labelled Comp Radiopharm; 2013 Nov; 56(13):663-71. PubMed ID: 25196028
    [Abstract] [Full Text] [Related]

  • 34. Monte Carlo characterization of biocompatible beta-emitting 90Y glass seed incorporated with the radionuclide 153Sm as a SPECT marker for brachytherapy applications.
    Hadadi A, Sadeghi M, Sardari D, Khanchi A, Shirazi A.
    J Appl Clin Med Phys; 2013 Sep 06; 14(5):90-103. PubMed ID: 24036862
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ, Chen JC, Cai Z, Chan C, Reilly RM.
    J Nucl Med; 2016 Mar 06; 57(3):444-52. PubMed ID: 26429962
    [Abstract] [Full Text] [Related]

  • 39. Dosimetric characterization of a novel 90Y source for use in the conformal superficial brachytherapy device.
    Rogers B, Lawrence J, Chmura J, Ehler E, Ferreira C.
    Phys Med; 2020 Apr 06; 72():52-59. PubMed ID: 32200298
    [Abstract] [Full Text] [Related]

  • 40. The use of directional interstitial sources to improve dosimetry in breast brachytherapy.
    Lin L, Patel RR, Thomadsen BR, Henderson DL.
    Med Phys; 2008 Jan 06; 35(1):240-7. PubMed ID: 18293579
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.